Home › Stocks › ORIC › All Fund Holders
ORIC — ORIC PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 40 · Reported value held: $476.87M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 6.82M | $73.90M | 0.00% | Add |
| Viking Global Investors history | Q2 2026 | 5.13M | $55.52M | 0.16% | Reduce |
| Alkeon Capital Management history | Q2 2026 | 3.74M | $40.49M | 0.06% | Reduce |
| Vanguard Group history | Q4 2025 | 4.54M | $37.15M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 2.64M | $28.54M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 2.62M | $28.39M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 2.45M | $26.55M | 0.00% | Add |
| Point72 Asset Management history | Q4 2025 | 2.92M | $23.91M | 0.03% | Add |
| Geode Capital Management history | Q2 2026 | 2.09M | $22.64M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 1.80M | $19.47M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 1.79M | $19.43M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 1.58M | $17.11M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 1.08M | $11.68M | 0.00% | Add |
| Royce & Associates history | Q2 2026 | 979.66K | $10.61M | 0.09% | Reduce |
| Northern Trust Corp history | Q2 2026 | 806.30K | $8.73M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 697.69K | $7.56M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 677.82K | $7.34M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 603.66K | $6.54M | 0.01% | New |
| Renaissance Technologies history | Q4 2025 | 572.72K | $4.68M | 0.01% | Add |
| AQR Capital Management history | Q2 2026 | 358.75K | $3.89M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 308.27K | $3.13M | 0.00% | New |
| Casdin Capital history | Q2 2022 | 601.51K | $2.69M | 0.23% | Hold |
| Citigroup Inc history | Q2 2026 | 248.76K | $2.69M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 222.92K | $2.41M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 220.08K | $2.38M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 213.37K | $2.31M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 174.22K | $1.89M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 107.77K | $1.17M | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 87.01K | $942.31K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 73.88K | $800.10K | 0.00% | Add |
| Moore Capital Management history | Q1 2026 | 59.56K | $754.66K | 0.02% | New |
| Legal & General Investment Management America history | Q2 2026 | 30.67K | $332.28K | 0.00% | Add |
| Marshall Wace history | Q1 2025 | 47.70K | $266.14K | 0.00% | New |
| Balyasny Asset Management history | Q2 2026 | 24.20K | $262.10K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 18.93K | $204.96K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 14.40K | $182.23K | 0.00% | Hold |
| CPP Investments history | Q2 2026 | 11.80K | $127.79K | 0.00% | New |
| PNC Financial Services history | Q1 2026 | 8.01K | $101.49K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 6.62M | $71.67K | 0.01% | Add |
| Amundi US history | Q1 2025 | 178 | $936 | 0.00% | New |